Welcome to our dedicated page for Nutex Health news (Ticker: NUTX), a resource for investors and traders seeking the latest updates and insights on Nutex Health stock.
Nutex Health Inc. (NASDAQ: NUTX) is a Houston, Texas-based, physician-led healthcare management and operations company with a growing network of micro-hospitals, specialty hospitals and hospital outpatient departments, along with primary care-centric, risk-bearing physician networks. The Nutex Health news feed highlights how this integrated healthcare delivery system evolves through facility openings, reopenings, financial results and corporate actions.
Investors and observers can use the Nutex Health news page to follow announcements about new and reopened hospitals such as Bayou City ER & Hospital near Houston, Red River ER & Hospital in Sherman, Texas, and Archview ER & Hospital in St. Louis, Missouri. These updates often describe facility capabilities, including emergency and inpatient beds, full-service laboratories and advanced imaging technology, as well as the company’s stated focus on concierge-level care and access to services around the clock.
Regular news releases also cover Nutex Health’s quarterly and annual financial results, segment performance for its hospital and population health management divisions, and non-GAAP measures such as EBITDA and Adjusted EBITDA. The company uses these reports to discuss revenue trends, hospital visit volumes, arbitration-related revenue through the Independent Dispute Resolution (IDR) process and cash flow from operating activities. Other items appearing in Nutex Health news include restatements of prior financial statements, Nasdaq listing compliance updates, stock repurchase program authorizations and information about legal or regulatory matters such as short seller reports and derivative litigation.
By reviewing the Nutex Health (NUTX) news page, readers can track how the company’s facility footprint, financial profile and governance disclosures change over time. The page aggregates press releases and related updates in one place, making it easier to monitor developments that the company has chosen to highlight in its public communications.
Nutex Health Inc. (NASDAQ: NUTX), a physician-led integrated healthcare delivery system, has announced its schedule for releasing 2024 second quarter financial results. The company, which operates 21 micro hospitals across 9 states and manages primary care-centric, risk-bearing physician networks, will disclose its financial performance on Thursday, August 8, 2024, after the stock market closes.
A conference call to discuss these results is scheduled for Friday, August 9, 2024, at 10:00 am ET. Investors and interested parties can participate by dialing 1-877-407-9208 or 1-201-493-6784. Alternatively, a webcast will be available for those who prefer to join online. For those unable to attend the live call, a recording will be accessible on the company's website.
Nutex Health Inc. (NASDAQ: NUTX) has successfully regained compliance with Nasdaq's minimum bid price requirement. This follows the company's 1:10 reverse stock split on July 3, 2024, after which the closing bid price of Nutex Health's common stock remained above $1.00 per share until July 23, 2024. The Nasdaq Stock Market has formally notified Nutex Health of its compliance with Listing Rule 5550(a)(2), considering the previous bid price deficiency matter closed.
Nutex Health operates as a physician-led, technology-enabled integrated healthcare delivery system, comprising 21 state-of-the-art micro hospitals across 9 states and primary care-centric, risk-bearing physician networks. This development ensures the company's continued listing on the Nasdaq Capital Market, as mandated by the Hearing Panel's decision on June 14, 2024.
Nutex Health (NASDAQ: NUTX) announced that its hospitals received nine awards and honors in Q2 2024, highlighting their commitment to patient care excellence. The awards, voted on by local communities, span across multiple facilities:
- Texarkana ER & Hospital won three 'Best Emergency Care' awards and a Distinguished Citizen Honor for their CMO.
- Tulsa ER & Hospital staff received recognition as an 'Influential Woman' and 'Face of Emergency Care'.
- NW Indiana ER & Hospital was named 'Best Hospital' for the fourth consecutive year.
- Royse City Emergency Hospital earned 'Business of the Year' for community impact.
- Albuquerque ER & Hospital was recognized as 'Best Place to Work' for the third year.
These accolades reflect Nutex Health's focus on superior healthcare delivery and patient satisfaction across its 21 micro hospitals in nine states.
Nutex Health announced a 1-for-10 reverse stock split effective July 3, 2024. The reverse split aims to regain compliance with Nasdaq's minimum bid price requirement. Authorized by shareholders on June 17, 2024, the split will reduce common shares from 49 million to 4.9 million but maintain the authorized shares at 950 million. No fractional shares will be issued; instead, shares will be rounded up to the nearest whole number. The split will also proportionately adjust shares reserved for equity compensation and outstanding warrants and stock options.
Nutex Health has received shareholder approval to effect a reverse stock split ranging from 1-for-2 to 1-for-16. This move aims to comply with NASDAQ’s minimum bid price requirement before the July 22, 2024 deadline. The reverse split follows a notice from NASDAQ granting the company an exception to meet the requirement. Nutex Health operates 21 micro hospitals across nine states and integrates healthcare delivery with technology-driven physician networks. Although the reverse stock split is targeted at meeting compliance, the company cannot assure it will achieve the desired market price effects.
On May 24, 2024, Nutex Health (NASDAQ: NUTX) received a Nasdaq staff determination letter indicating non-compliance with the $1.00 bid price requirement, leading to potential delisting. Nutex Health has requested a hearing scheduled for July 9, 2024, to appeal the decision, resulting in a stay of the delisting action. The company is also considering a reverse stock split, pending shareholder approval on June 17, 2024, to meet the minimum bid price requirement. The stock will continue trading on Nasdaq during this period.
Nutex Health Inc. reports first quarter 2024 financial results with total revenue of $67.5 million, a 20% increase from 2023, hospital division visits up by 21.1%, and operating income up by 119%. The company focuses on cash flow, reduction in expenses, and portfolio optimization, maintaining a strong balance sheet.
Nutex Health Inc. (NASDAQ: NUTX) will release its first-quarter financial results on May 8, 2024, discussing them in a conference call on May 10, 2024. The company operates 21 micro hospitals in 9 states and primary care-centric physician networks.
Nutex Health Inc. announces the availability of proxy materials for its 2024 Annual Meeting to be held virtually on June 17, 2024. Stockholders can access the materials online or request a paper or email copy before June 3, 2024. The Company is using a 'notice only' option for proxy material delivery, with stockholders receiving the 'Notice Regarding the Availability of Proxy Materials' 40 days before the meeting.
Summary not available.
FAQ
What is the current stock price of Nutex Health (NUTX)?
What is the market cap of Nutex Health (NUTX)?
